Diagnosis and Treatment of Respiratory Illness in Children and Adults Non-Infectious Rhinitis Algorithm

Total Page:16

File Type:pdf, Size:1020Kb

Diagnosis and Treatment of Respiratory Illness in Children and Adults Non-Infectious Rhinitis Algorithm Health Care Guideline: Diagnosis and Treatment of Respiratory Illness in Children and Adults Non-Infectious Rhinitis Algorithm Patient presents with symptoms of non-infectious rhinitis History/physical Consider RAST* and skin yes testing when definitive Signs and symptoms no Signs and symptoms Consider referral to diagnosis is needed suggest allergic suggest structural specialist etiology? etiology? yes no * Radioallergosorbent test Treatment options Non-allergic • Education on avoidance rhinitis • Medications - Intranasal corticosteroids - Intranasal antihistamines - Oral antihistamines Treatment options - Combination intranasal • Medications antihistamines/intranasal corticosteroids - Intranasal antihistamines - Leukotriene blockers - Decongestants - Anticholinergics - Intranasal corticosteroids - Decongestants - Intranasal ipraptropium bromide • Patient education Adequate yes • Patient education Adequate yes • Follow-up as response? • Follow-up as appropriate response? appropriate no no Consider referral • Consider testing to a specialist • Consider referral to a specialist www.icsi.org Copyright © 2017 by Institute for Clinical Systems Improvement 1 Diagnosis and Treatment of Respiratory Illness in Children and Adults Fifth Edition/September 2017 Acute Pharyngitis Algorithm Patient presents with symptoms of GAS* pharyngitis History/physical Shared decision-making Consider strep testing Do not routinely test if Centor (RADT**, throat culture, criteria < 3 or when viral features PCR***) based on clinical like rhinorrhea, cough, oral ulcers presentation and/or hoarseness are present Shared decision-making Treatment options Rapid test results yes • Symptomatic treatment show strep • Immediate antibiotics present? • Delayed antibiotics no • Symptomatic treatment Backup strep culture • Consider alternative for children Persistent no Follow-up as diagnoses infection/treatment needed failure? yes no Strep culture yes • Consider re-evaluation positive? for alternative diagnoses • Consider carrier state * Group A streptococcal ** Rapid antigen detection test *** Polymerase chain reaction www.icsi.org Institute for Clinical Systems Improvement 2 Diagnosis and Treatment of Respiratory Illness in Children and Adults Fifth Edition/September 2017 Non-Infectious Rhinitis Algorithm Patient presents with symptoms of non-infectious rhinitis History/physical Consider RAST* and skin yes testing when definitive Signs and symptoms no Signs and symptoms Consider referral to diagnosis is needed suggest allergic suggest structural specialist etiology? etiology? yes no * Radioallergosorbent test Treatment options Non-allergic • Education on avoidance rhinitis • Medications - Intranasal corticosteroids - Intranasal antihistamines - Oral antihistamines Treatment options - Combination intranasal • Medications antihistamines/intranasal corticosteroids - Intranasal antihistamines - Leukotriene blockers - Decongestants - Anticholinergics - Intranasal corticosteroids - Decongestants - Intranasal ipraptropium bromide • Patient education Adequate yes • Patient education Adequate yes • Follow-up as response? • Follow-up as appropriate response? appropriate no no Consider referral • Consider testing to a specialist • Consider referral to a specialist www.icsi.org Institute for Clinical Systems Improvement 3 Diagnosis and Treatment of Respiratory Illness in Children and Adults Fifth Edition/September 2017 Acute Sinusitis Algorithm Patient presents with symptoms suggestive of acute bacterial rhinosinusitis (ABRS) History/physical Diagnosis of ABRS Two clinical presentations where ABRS have a higher likelihood of being present: • Persistence of symptoms consistent with Does patient have no Consider alternative acute rhinosinusitis lasting 10 days or signs and symptoms diagnoses more without evidence of improvement of ABRS? • Symptoms are worsening – new onset of yes fever, headache or increase in nasal Shared discharge after a viral upper respiratory Treatment options decision-making infection that lasted 5-6 days and the patient • Symptomatic care was initially improving (double worsening - Comfort measures or double sickening) - Decongestants • Severe symptoms and high fever of 102ºF - Intranasal corticosteroids for at least 3-4 days from onset of illness • Consider immediate or delayed should not routinely be used as criteria to antibiotics based on the degree of diagnose ABRS. The diagnosis should be illness, comorbidities and after made on an individualized basis depending shared decision-making discussion on the entire clinical scenario. with patients who meet criteria for ABRS Re-evaluate • Start on antibiotic if not done Adequate • Consider changing an antibiotic no response to • Consider further evaluation and treatment? imaging yes • Consider alternative diagnoses • Consider referral to a specialist Continue plan of care and follow-up www.icsi.org Institute for Clinical Systems Improvement 4 Diagnosis and Treatment of Respiratory Illness in Children and Adults Fifth Edition/September 2017 Table of Contents Work Group Leader Algorithms and Annotations ........................................................................................ 1-48 Sonja Short, MD Algorithm – Main .................................................................................................................1 Internal Medicine and Algorithm – Acute Pharyngitis .............................................................................................2 Pediatrics, Fairview Health Algorithm – Non-Infectious Rhinitis ...................................................................................3 Services Algorithm – Acute Sinusitis .................................................................................................4 Work Group Members Evidence Grading .................................................................................................................7 Fairview Health Services Hiba Bashir, MD Recommendations Table .................................................................................................. 8-9 Allergy/Immunology Foreword Danielle Olmschenk, PharmD Pharmacy Introduction ...................................................................................................................10 HealthPartners Scope and Target Population .........................................................................................10 Peter Marshall, PharmD Aims ..............................................................................................................................10 Pharmacy Implementation Recommendation Highlights ..............................................................11 Mayo Clinic Annotations .................................................................................................................. 12-48 Nathaniel Miller, MD 1. Initial Presentation ............................................................................................. 12-13 Family Medicine 2. Viral Upper-Respiratory Infections .................................................................... 14-21 Kimberly Prigge, APRN, Causes ......................................................................................................................14 CNP Family Medicine History/Physical ................................................................................................ 14-15 Diagnosis .................................................................................................................15 South Lake Pediatrics Laura Solyntjes, MD Treatment ........................................................................................................... 16-20 Pediatrics Follow-Up ...............................................................................................................20 ICSI Prevention .......................................................................................................... 20-21 Jodie Dvorkin, MD, MPH 3. Acute Pharyngitis ............................................................................................... 21-29 Project Manager/Health Care Causes ......................................................................................................................21 Consultant History/Physical ......................................................................................................22 Senka Hadzic, MPH Diagnosis ........................................................................................................... 22-24 Clinical Systems Improvement Treatment ........................................................................................................... 24-27 Facilitator Re-Evaluation .................................................................................................... 27-28 Carrier State .............................................................................................................28 Complications of GAS ...................................................................................... 28-29 4. Non-Infectious Rhinitis ...................................................................................... 29-38 Causes ......................................................................................................................29 History/Physical ................................................................................................ 30-32 Diagnosis ........................................................................................................... 32-33 Treatment for Allergic Rhinitis
Recommended publications
  • Allergic Bronchopulmonary Aspergillosis Revealing Asthma
    CASE REPORT published: 22 June 2021 doi: 10.3389/fimmu.2021.695954 Case Report: Allergic Bronchopulmonary Aspergillosis Revealing Asthma Houda Snen 1,2*, Aicha Kallel 2,3*, Hana Blibech 1,2, Sana Jemel 2,3, Nozha Ben Salah 1,2, Sonia Marouen 3, Nadia Mehiri 1,2, Slah Belhaj 3, Bechir Louzir 1,2 and Kalthoum Kallel 2,3 1 Pulmonary Department, Hospital Mongi Slim, La Marsa, Tunisia, 2 Faculty of Medicine, Tunis El Manar University, Tunis, Tunisia, 3 Parasitology and Mycology Department, La Rabta Hospital, Tunis, Tunisia Allergic bronchopulmonary aspergillosis (ABPA) is an immunological pulmonary disorder caused by hypersensitivity to Aspergillus which colonizes the airways of patients with asthma and cystic fibrosis. Its diagnosis could be difficult in some cases due to atypical Edited by: presentations especially when there is no medical history of asthma. Treatment of ABPA is Brian Stephen Eley, frequently associated to side effects but cumulated drug toxicity due to different molecules University of Cape Town, South Africa is rarely reported. An accurate choice among the different available molecules and Reviewed by: effective on ABPA is crucial. We report a case of ABPA in a woman without a known Shivank Singh, Southern Medical University, China history of asthma. She presented an acute bronchitis with wheezing dyspnea leading to an Richard B. Moss, acute respiratory failure. She was hospitalized in the intensive care unit. The Stanford University, United States bronchoscopy revealed a complete obstruction of the left primary bronchus by a sticky *Correspondence: Houda Snen greenish material. The culture of this material isolated Aspergillus fumigatus and that of [email protected] bronchial aspiration fluid isolated Pseudomonas aeruginosa.
    [Show full text]
  • Infections of the Respiratory Tract
    F70954-07.qxd 12/10/02 7:36 AM Page 71 Infections of the respiratory 7 tract the nasal hairs and by inertial impaction with mucus- 7.1 Pathogenesis 71 covered surfaces in the posterior nasopharynx (Fig. 11). 7.2 Diagnosis 72 The epiglottis, its closure reflex and the cough reflex all reduce the risk of microorganisms reaching the lower 7.3 Management 72 respiratory tract. Particles small enough to reach the tra- 7.4 Diseases and syndromes 73 chea and bronchi stick to the respiratory mucus lining their walls and are propelled towards the oropharynx 7.5 Organisms 79 by the action of cilia (the ‘mucociliary escalator’). Self-assessment: questions 80 Antimicrobial factors present in respiratory secretions further disable inhaled microorganisms. They include Self-assessment: answers 83 lysozyme, lactoferrin and secretory IgA. Particles in the size range 5–10 µm may penetrate further into the lungs and even reach the alveolar air Overview spaces. Here, alveolar macrophages are available to phagocytose potential pathogens, and if these are overwhelmed neutrophils can be recruited via the This chapter deals with infections of structures that constitute inflammatory response. The defences of the respira- the upper and lower respiratory tract. The general population tory tract are a reflection of its vulnerability to micro- commonly experiences upper respiratory tract infections, bial attack. Acquisition of microbial pathogens is which are often seen in general practice. Lower respiratory tract infections are less common but are more likely to cause serious illness and death. Diagnosis and specific chemotherapy of respiratory tract infections present a particular challenge to both the clinician and the laboratory staff.
    [Show full text]
  • Rhinitis and Sinusitis
    Glendale Animal Hospital 623-934-7243 www.familyvet.com Rhinitis and Sinusitis (Inflammation of the Nose and Sinuses) Basics OVERVIEW Rhinitis—inflammation of the lining of the nose Sinusitis—inflammation of the sinuses The nasal cavity communicates directly with the sinuses; thus inflammation of the nose (rhinitis) and inflammation of the sinuses (sinusitis) often occur together (known as “rhinosinusitis”) “Upper respiratory tract” (also known as the “upper airways”) includes the nose, nasal passages, throat (pharynx), and windpipe (trachea) “Lower respiratory tract” (also known as the “lower airways”) includes the bronchi, bronchioles, and alveoli (the terminal portion of the airways, in which oxygen and carbon dioxide are exchanged) SIGNALMENT/DESCRIPTION OF PET Species Dogs Cats Breed Predilections Short-nosed, flat-faced (known as “brachycephalic”) cats are more prone to long-term (chronic) inflammation of the nose (rhinitis), and possibly fungal rhinitis Dogs with a long head and nose (known as “dolichocephalic dogs,” such as the collie and Afghan hound) are more prone to Aspergillus (a type of fungus) infection and nasal tumors Mean Age and Range Cats—sudden (acute) viral inflammation of the nose and sinuses (rhinosinusitis) and red masses in the nasal cavity and throat (known as “nasopharyngeal polyps”) are more common in young kittens (6–12 weeks of age) Congenital (present at birth) diseases (such as cleft palate) are more common in young pets Tumors/cancer and dental disease—are more common in older pets Foreign
    [Show full text]
  • Retropharyngeal Cellulitis in a 5-Week-Old Infant
    Retropharyngeal Cellulitis in a 5-Week-Old Infant Florence T. Bourgeois, MD*, and Michael W. Shannon, MD, MPH‡ ABSTRACT. An infant who presents with acute, unex- abnormalities. An abdominal radiograph was also unremarkable. plained crying requires a thorough examination to iden- Initial laboratory studies revealed a leukocyte count of 3900/mm3 tify the source of distress. We report the case of a 5-week- (12% band forms, 28% segmented neutrophils, 4% monocytes, 49% old infant who had sudden irritability and was found to lymphocytes, 1% eosinophils), a hematocrit of 37%, and a platelet count of 299 000/mm3. Urinalysis was negative. have retropharyngeal cellulitis caused by group B The infant continued to be extremely irritable and refused all Streptococcus. Pediatrics 2002;109(3). URL: http://www. feeds. He could be comforted intermittently, but any repositioning pediatrics.org/cgi/content/full/109/3/e51; group B Strepto- distressed him. Because of the sudden onset of the child’s symp- coccus, retropharyngeal cellulitis, infant, irritability. toms and his unwillingness to be moved, the question of acute injury was raised and a skeletal survey was performed. While obtaining the radiographs, it was noted that the child would calm ABBREVIATION. GBS, group B streptococcal. down when his neck was positioned in hyperextension. Lateral cervical spine films showed prominence of the prevertebral soft tissues, and a fluoroscopic assessment of the airway demonstrated rying is an infant’s principle form of commu- retropharyngeal soft tissue swelling, which persisted with the nication. Usually an infant’s source of distress neck in both flexed and extended positions. The remainder of the can be identified easily, and the child can be skeletal survey was negative.
    [Show full text]
  • Respiratory Syncytial Virus Bronchiolitis in Children DUSTIN K
    Respiratory Syncytial Virus Bronchiolitis in Children DUSTIN K. SMITH, DO; SAJEEWANE SEALES, MD, MPH; and CAROL BUDZIK, MD Naval Hospital Jacksonville, Jacksonville, Florida Bronchiolitis is a common lower respiratory tract infection in infants and young children, and respiratory syncytial virus (RSV) is the most common cause of this infection. RSV is transmitted through contact with respiratory droplets either directly from an infected person or self-inoculation by contaminated secretions on surfaces. Patients with RSV bronchiolitis usually present with two to four days of upper respiratory tract symptoms such as fever, rhinorrhea, and congestion, followed by lower respiratory tract symptoms such as increasing cough, wheezing, and increased respira- tory effort. In 2014, the American Academy of Pediatrics updated its clinical practice guideline for diagnosis and man- agement of RSV bronchiolitis to minimize unnecessary diagnostic testing and interventions. Bronchiolitis remains a clinical diagnosis, and diagnostic testing is not routinely recommended. Treatment of RSV infection is mainly sup- portive, and modalities such as bronchodilators, epinephrine, corticosteroids, hypertonic saline, and antibiotics are generally not useful. Evidence supports using supplemental oxygen to maintain adequate oxygen saturation; however, continuous pulse oximetry is no longer required. The other mainstay of therapy is intravenous or nasogastric admin- istration of fluids for infants who cannot maintain their hydration status with oral fluid intake. Educating parents on reducing the risk of infection is one of the most important things a physician can do to help prevent RSV infection, especially early in life. Children at risk of severe lower respiratory tract infection should receive immunoprophy- laxis with palivizumab, a humanized monoclonal antibody, in up to five monthly doses.
    [Show full text]
  • Review of the Existing Recommendations for Essential Medicines for Ear, Nose and Throat Conditions in Adults and Children and Suggested Modifications
    REVIEW OF THE EXISTING RECOMMENDATIONS FOR ESSENTIAL MEDICINES FOR EAR, NOSE AND THROAT CONDITIONS IN ADULTS AND CHILDREN AND SUGGESTED MODIFICATIONS 2012 Shelly Chadha, Andnet Kebede Prevention of Blindness and Deafness, World Health Organization REVIEW OF THE EXISTING RECOMMENDATIONS FOR ESSENTIAL MEDICINES (Ear, Nose and Throat conditions) FOR USE IN ADULTS AND CHILDREN AND SUGGESTED MODIFICATIONS Context: The WHO Essential Medicines List includes a section for ENT conditions in children. The current section does not make any reference to medicines and dosages recommended for adults. As most of the conditions for which the listed medicines are indicated, are common in adults, the list needs to be appropriately reviewed in that context. Methodology: Each of the medicines listed in the EML for children was reviewed to consider its appropriateness for inclusion in the EML for adults. The recommended dosages for adults and children were also considered. Recommendations: The medicine list should include a list for adults as well as children. The list for adults should include Xylometazoline hydrochloride nasal spray 0.1%. It should be stated that the medicine (xylometazoline nasal spray) should not be used for prolonged periods of time, unless specifically advised and under medical supervision. The adult list should also include the other medicines mentioned in the list of children, i.e.: o Ciprofloxacin ear drops: 0.3%, as hydrochloride, for tropical use. o Aectic acid ear drops, 2% in alcohol, for topical use. Budesonide nasal spray listed in the EML for children needs greater, in depth review, which may be considered for the next EML update. 1 Xylometazoline Hydrochloride nasal spray Indications: Nasal congestion is obstruction of nasal passages, mainly caused by mucosal inflammation due to increased venous engorgement, nasal secretions and tissue swelling.
    [Show full text]
  • Care Process Models Streptococcal Pharyngitis
    Care Process Model MONTH MARCH 20152019 DEVELOPMENTDIAGNOSIS AND AND MANAGEMENT DESIGN OF OF CareStreptococcal Process Models Pharyngitis 20192015 Update This care process model (CPM) was developed by Intermountain Healthcare’s Antibiotic Stewardship team, Medical Speciality Clinical Program,Community-Based Care, and Intermountain Pediatrics. Based on expert opinion and the Infectious Disease Society of America (IDSA) Clinical Practice Guidelines, it provides best-practice recommendations for diagnosis and management of group A streptococcal pharyngitis (strep) including the appropriate use of antibiotics. WHAT’S INSIDE? KEY POINTS ALGORITHM 1: DIAGNOSIS AND TREATMENT OF PEDIATRIC • Accurate diagnosis and appropriate treatment can prevent serious STREPTOCOCCAL PHARYNGITIS complications . When strep is present, appropriate antibiotics can prevent AGES 3 – 18 . 2 SHU acute rheumatic fever, peritonsillar abscess, and other invasive infections. ALGORITHM 2: DIAGNOSIS Treatment also decreases spread of infection and improves clinical AND TREATMENT OF ADULT symptoms and signs for the patient. STREPTOCOCCAL PHARYNGITIS . 4 • Differentiating between a patient with an active strep infection PHARYNGEAL CARRIERS . 6 and a patient who is a strep carrier with an active viral pharyngitis RESOURCES AND REFERENCES . 7 is challenging . Treating patients for active strep infection when they are only carriers can result in overuse of antibiotics. Approximately 20% of asymptomatic school-aged children may be strep carriers, and a throat culture during a viral illness may yield positive results, but not require antibiotic treatment. SHU Prescribing repeat antibiotics will not help these patients and can MEASUREMENT & GOALS contribute to antibiotic resistance. • Ensure appropriate use of throat • For adult patients, routine overnight cultures after a negative rapid culture for adult patients who meet high risk criteria strep test are unnecessary in usual circumstances because the risk for acute rheumatic fever is exceptionally low.
    [Show full text]
  • Other Work-Related Respiratory Disease Statistics in Great Britain, 2020 Allergic Alveolitis, Byssinosis and Allergic Rhinitis
    Health and Safety Executive Data up to December 2019 Annual Statistics Published 4th November 2019 Other work-related respiratory disease statistics in Great Britain, 2020 Allergic alveolitis, byssinosis and allergic rhinitis Contents Other respiratory diseases 2 Farmer's lung and other allergic alveolitis 2 Byssinosis 3 Allergic rhinitis 3 The document can be found at: www.hse.gov.uk/statistics/causdis/ This document is available from www.hse.gov.uk/statistics/ Page 1 of 4 Other respiratory diseases This document outlines the available statistics for occupational respiratory diseases other than asbestos- related disease, asthma, Chronic Obstructive Pulmonary Disease (COPD) and pneumoconiosis which are covered elsewhere – see https://www.hse.gov.uk/statistics/causdis/index.htm. Farmer's lung and other allergic alveolitis Occupational Extrinsic Allergic Alveolitis (EAA) – also known as Occupational Hypersensitivity Pneumonitis – is inflammation of the alveoli within the lungs caused by an allergic reaction to inhaled material. “Farmer's lung”, which is caused by the inhalation of dust or spores arising from mouldy hay, grain or straw, is a common form of the disease. It is typically characterised by acute flu-like effects but can, in some cases, also lead to serious longer-term effects on lung function. There has been an average of 7 new cases of occupational EAA assessed for Industrial Injuries Disablement Benefit (IIDB) each year over the last decade, with about 15% of total cases being among women (Table IIDB01 www.hse.gov.uk/statistics/tables/iidb01.xlsx). There has also been an average of 7 deaths where farmer's lung (or a similar condition) was recorded as the underlying cause each year over the last decade (Table DC01 www.hse.gov.uk/statistics/tables/dc01.xlsx), with less than 10% of total deaths among women.
    [Show full text]
  • Intranasal Ipratropium Bromide Reduced Rhinorrhea and Improved Cold Symptoms
    /:*-..= S Evid Based Med: first published as 10.1136/ebm.1996.1.205 on 1 December 1996. Downloaded from Intranasal ipratropium bromide reduced rhinorrhea and improved cold symptoms Hayden FG, Diamond L, Wood PB, 0.06% in a buffered salt solution (P = 0.003). {This 17% absolute dif- KortsDC, Wecker MT. Effectiveness (2 sprays/nostril [84 u,g] 3 times/d ference in improvement between the and safety of intranasal ipratropium for 4 d) (n = 137), the same nasal ipratropium and placebo groups bromide in common colds. A ran- spray without ipratropium in = 137), means that 6 patients (95% CI, 4 to domized, double-blind, placebo- or no medication (n = 137). No cold 16) would need to be treated with controlled trial. Ann Intern Med. medications other than analgesics ipratropium (rather than placebo) for 1996JullS;12S:89-91. and antitussives were allowed. 4 days to result in improvement for 1 additional patient; the relative risk Main outcome measures improvement was 26%, CI 9% to Objective 47%* }. Rates of nasal dryness (12% To determine whether intxanasal ipra- The main outcome measure was a vs 4%), blood-tinged mucus (17% vs tropium bromide is effective and safe global assessment of overall improve- 4%), and headache (9% vs 2%) were for reducing common cold symptoms. ment (report by patients of being better or much better). Rhinorrhea greater in the ipratropium group than Design was monitored in the clinic hourly in the placebo group. 6-day, randomized, double-blind, for the first 6 hours on day 1 and Conclusion placebo-controlled trial. hourly for 3 hours on day 2.
    [Show full text]
  • Allergic/Non-Allergic Rhinitis
    Tips to Remember: Rhinitis Do you have a runny or stuffy nose that doesn't seem to go away? If so, you may have rhinitis, which is an inflammation of the mucous membranes of the nose. Rhinitis is one of the most common allergic conditions in the United States, affecting about 40 million people. It often coexists with other allergic disorders, such as asthma. It is important to treat rhinitis because it can contribute to other conditions such as sleep disorders, fatigue and learning problems. There are two general types of rhinitis: Allergic rhinitis is caused by substances called allergens. Allergens are often common, usually harmless substances that can cause an allergic reaction in some people. Causes • When allergic rhinitis is caused by common outdoor allergens, such as airborne tree, grass and weed pollens or mold, it is called seasonal allergic rhinitis, or "hay fever." • Allergic rhinitis is also triggered by common indoor allergens, such as animal dander (dried skin flakes and saliva), indoor mold or droppings from cockroaches or dust mites. This is called perennial allergic rhinitis. Symptoms • Sneezing • Congestion • Runny nose • Itchiness in the nose, roof of the mouth, throat, eyes and ears Diagnosis If you have symptoms of allergic rhinitis, an allergist/immunologist can help determine which specific allergens are triggering your reaction. He or she will take a thorough health history, and then test you to determine if you have allergies. Skin tests or Blood (RAST) tests are the most common methods for determining your allergic triggers. Treatment Once your allergic triggers are determined, your physician or nurse will work with you to develop a plan to avoid the allergens that trigger your symptoms.
    [Show full text]
  • Allergic Fungal Airway Disease Rick EM, Woolnough K, Pashley CH, Wardlaw AJ
    REVIEWS Allergic Fungal Airway Disease Rick EM, Woolnough K, Pashley CH, Wardlaw AJ Institute for Lung Health, Department of Infection, Immunity & Inflammation, University of Leicester and Department of Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK J Investig Allergol Clin Immunol 2016; Vol. 26(6): 344-354 doi: 10.18176/jiaci.0122 Abstract Fungi are ubiquitous and form their own kingdom. Up to 80 genera of fungi have been linked to type I allergic disease, and yet, commercial reagents to test for sensitization are available for relatively few species. In terms of asthma, it is important to distinguish between species unable to grow at body temperature and those that can (thermotolerant) and thereby have the potential to colonize the respiratory tract. The former, which include the commonly studied Alternaria and Cladosporium genera, can act as aeroallergens whose clinical effects are predictably related to exposure levels. In contrast, thermotolerant species, which include fungi from the Candida, Aspergillus, and Penicillium genera, can cause a persistent allergenic stimulus independent of their airborne concentrations. Moreover, their ability to germinate in the airways provides a more diverse allergenic stimulus, and may result in noninvasive infection, which enhances inflammation. The close association between IgE sensitization to thermotolerant filamentous fungi and fixed airflow obstruction, bronchiectasis, and lung fibrosis suggests a much more tissue-damaging process than that seen with aeroallergens. This review provides an overview of fungal allergens and the patterns of clinical disease associated with exposure. It clarifies the various terminologies associated with fungal allergy in asthma and makes the case for a new term (allergic fungal airway disease) to include all people with asthma at risk of developing lung damage as a result of their fungal allergy.
    [Show full text]
  • Retropharyngeal Abscess Complicated
    RETROPHARYNGEAL ABSCESS COMPLICATED Ortega Coronel María Fernanda, Dr. Calvopiña José Dr. Mena Glennª ª Departamento de Radiología e Imagen del Hospital Eugenio Espejo Quito Ecuador _________________________________ Revista de la Federación Ecuatoriana de Sociedades de Radiología, Ecuador 2011 N° 4, Pag, 9 -11. ABSTRACT It is a concise review of retropharyngeal abscess, we report a case of long and torpid evolution with multiple subtreatments that masked the symptoms for a long time, increasing the risk of provoking severe morbidity and complications. the cervical spine, presence of air or INTRODUCTION foreign body in soft tissue. CT is useful for Retropharyngeal abscess is defined by the diagnosis of early-stage infections while infection between the posterior pharyngeal allows differentiation between cellulitis wall and the prevertebral fascia, it is an and abscess, is also useful in defining the uncommon condition, most common in vascular structures and their relationship children by extension of oropharyngeal to the infectious process defines exactly infections 1, in adults is caused by trauma like that space or spaces are involve. 7 MRI after ingestion of foreing bodies that has a higher resolution than CT and is able damage the esophagus or the trachea, to evaluate the retropharyngeal space with tracheal intubation and less frequently a series of sequences, including diffusion. untimely tooth infections.2 Many studies But this test is not used routinely for the have shown that most of these abscesses diagnosis of this condition,
    [Show full text]